Altus Pharmaceuticals Inc. (ALTU) is a publicly traded company in the Unknown sector. Across all available filings, 18 corporate insiders have executed 176 transactions totaling $19.9M, demonstrating a bearish sentiment with -$19.9M in net insider flow. The most recent transaction on Apr 7, 2023 involved a transaction of 7,500,000 shares valued at $0.
No significant insider buying has been recorded for ALTU in the recent period.
No significant insider selling has been recorded for ALTU in the recent period.
Based on recent SEC filings, insider sentiment for ALTU is bearish with an Insider Alignment Score of 0/100 and a net flow of -$19.9M. Insiders are reducing their positions, though this can be driven by factors unrelated to company outlook.
Insider trading at Altus Pharmaceuticals Inc. (ALTU) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 18 insiders are actively trading ALTU stock, having executed 176 transactions in the past 90 days. The most active insider is Pharmaceuticals Inc /. Ma Vertex (Executive), who has made 2 transactions totaling $13.9M.
Get notified when executives and directors at ALTU file new Form 4 transactions
Date | Insider | Title | Type | Shares | Price | Value | Flags |
|---|---|---|---|---|---|---|---|
| Apr 7, 2023 | Teplis Gary | Executive | Conversion | 7,500,000 | $N/A | $0 | |
| Jul 19, 2022 | Arbitrage, Sa Bnp Paribas | Executive | Sale | 145,000 | $9.94 | $1.4M | Large |
| Jul 19, 2022 | Arbitrage, Sa Bnp Paribas | Executive | Sale | 250,000 | $9.94 | $2.5M | Large |
| Sep 14, 2009 | Partners VIII B. L. P. Usvp Entrepreneur | Executive | Sale | 1,472 | $0.32 | $471 | |
| Sep 14, 2009 | Partners VIII B. L. P. Usvp Entrepreneur | Executive | Sale | 2,756 | $0.32 | $882 | |
| Sep 14, 2009 | Partners VIII B. L. P. Usvp Entrepreneur | Executive | Sale | 2,161 | $0.32 | $692 | |
| Sep 14, 2009 | Partners VIII B. L. P. Usvp Entrepreneur | Executive | Sale | 293,611 | $0.32 | $94.0K | |
| Sep 14, 2009 | M. Young Philip | Executive | Sale | 2,161 | $0.32 | $692 | |
| Sep 14, 2009 | M. Young Philip | Executive | Sale | 293,611 | $0.32 | $94.0K | |
| Sep 14, 2009 | M. Young Philip | Executive | Sale | 1,472 | $0.32 | $471 | |
| Sep 14, 2009 | M. Young Philip | Executive | Sale | 2,756 | $0.32 | $882 | |
| Apr 20, 2009 | &. Co Warburg Pincus | Executive | Sale | 458,231 | $0.21 | $96.2K | |
| Apr 17, 2009 | &. Co Warburg Pincus | Executive | Sale | 276,219 | $0.21 | $58.0K | |
| Apr 16, 2009 | &. Co Warburg Pincus | Executive | Sale | 50,672 | $0.21 | $10.6K | |
| Apr 15, 2009 | Partners Llc Warburg Pincus | Executive | Sale | 129,798 | $0.21 | $27.3K |
| TYPE | COUNT | VALUE | % |
|---|---|---|---|
Sale(S) | 105 | $19.9M | 87.1% |
Conversion(C) | 20 | $2.2M | 9.6% |
Exercise(M) | 37 | $769.5K | 3.4% |
Other(J) | 14 | $0 | 0.0% |
Insider selling pressure at Altus Pharmaceuticals Inc. has increased, with 18 insiders executing 176 transactions across all time. Total sales of $19.9M significantly outpace purchases of $0, resulting in a net outflow of $19.9M. This selling activity appears largely discretionary, which may warrant closer attention from investors.